Guangdong Zhongsheng Pharmaceutical Co., Ltd.
SZSE:002317.SZ
17.26 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 2,610.55 | 2,676.152 | 2,429.095 | 1,895.824 | 2,531.516 | 2,361.506 | 1,964.235 | 1,692.486 | 1,577.737 | 1,308.517 | 1,090.028 | 886.433 | 750.644 | 640.715 | 551.603 | 484.305 | 404.403 | 326.897 |
Cost of Revenue
| 1,080.875 | 940.486 | 806.557 | 657.142 | 917.452 | 903.944 | 811.143 | 516.199 | 573.144 | 517.413 | 451.869 | 337.673 | 272.388 | 234.754 | 211.684 | 227.067 | 214.675 | 189.973 |
Gross Profit
| 1,529.675 | 1,735.665 | 1,622.538 | 1,238.682 | 1,614.064 | 1,457.562 | 1,153.092 | 1,176.287 | 1,004.592 | 791.104 | 638.159 | 548.76 | 478.255 | 405.961 | 339.919 | 257.238 | 189.728 | 136.924 |
Gross Profit Ratio
| 0.586 | 0.649 | 0.668 | 0.653 | 0.638 | 0.617 | 0.587 | 0.695 | 0.637 | 0.605 | 0.585 | 0.619 | 0.637 | 0.634 | 0.616 | 0.531 | 0.469 | 0.419 |
Reseach & Development Expenses
| 127.369 | 156.591 | 136.726 | 113.623 | 132.583 | 84.291 | 67.516 | 74.158 | 67.509 | 67.055 | 52.104 | 30.99 | 31.929 | 27.567 | 0 | 11.753 | 8.345 | 5.333 |
General & Administrative Expenses
| 48.034 | 41.562 | 57.987 | 50.508 | 56.517 | 47.216 | 34.967 | 24.002 | 30.263 | 20.476 | 15.392 | 11.597 | 12.56 | 9.786 | 37.05 | 10.334 | 9.244 | 7.538 |
Selling & Marketing Expenses
| 889.897 | 1,000.081 | 940.736 | 722.291 | 853.752 | 749.817 | 593.679 | 589.613 | 527.609 | 434.844 | 358.205 | 300.642 | 255.435 | 225.92 | 185.206 | 135.857 | 100.532 | 76.101 |
SG&A
| 937.931 | 1,041.644 | 998.723 | 772.799 | 910.269 | 797.033 | 628.646 | 613.615 | 557.872 | 455.32 | 373.598 | 312.239 | 267.995 | 235.706 | 222.256 | 146.192 | 109.776 | 83.639 |
Other Expenses
| -15.074 | 142.681 | 86.71 | 71.381 | 88.995 | -0.987 | -1.977 | 25.494 | 9.975 | 7.467 | 9.286 | 12.759 | -10.642 | -9.641 | 7.435 | 5.162 | -4.218 | 0.269 |
Operating Expenses
| 1,177.795 | 1,340.915 | 1,222.16 | 957.804 | 1,131.848 | 940.328 | 692.337 | 747.991 | 684.88 | 567.741 | 456.862 | 373.504 | 326.753 | 279.985 | 227.309 | 169.309 | 128.175 | 97.702 |
Operating Income
| 298.731 | 374.263 | 443.323 | 388.009 | 518.915 | 500.952 | 493.702 | 458.302 | 332.719 | 240.805 | 209.303 | 200.245 | 168.776 | 144.23 | 108.663 | 80.321 | 56.649 | 36.401 |
Operating Income Ratio
| 0.114 | 0.14 | 0.183 | 0.205 | 0.205 | 0.212 | 0.251 | 0.271 | 0.211 | 0.184 | 0.192 | 0.226 | 0.225 | 0.225 | 0.197 | 0.166 | 0.14 | 0.111 |
Total Other Income Expenses Net
| -62.553 | -5.96 | -133.845 | -733.281 | -140.037 | -17.27 | 30.97 | 55.095 | 22.19 | 24.903 | 36.683 | 37.551 | 23.65 | 27.177 | 2.135 | -2.475 | -9.692 | -2.746 |
Income Before Tax
| 283.657 | 368.302 | 309.478 | -345.272 | 378.877 | 499.965 | 491.725 | 483.391 | 341.903 | 248.265 | 217.98 | 212.807 | 175.152 | 153.152 | 114.746 | 85.453 | 51.861 | 36.476 |
Income Before Tax Ratio
| 0.109 | 0.138 | 0.127 | -0.182 | 0.15 | 0.212 | 0.25 | 0.286 | 0.217 | 0.19 | 0.2 | 0.24 | 0.233 | 0.239 | 0.208 | 0.176 | 0.128 | 0.112 |
Income Tax Expense
| 33.756 | 52.954 | 34.808 | 89.157 | 59.103 | 69.464 | 68.723 | 62.904 | 46.27 | 32.284 | 30.607 | 31.295 | 24.615 | 21.642 | 14.391 | 11.069 | 6.723 | 1.883 |
Net Income
| 263.273 | 322.05 | 277.631 | -434.429 | 317.729 | 435.648 | 420.121 | 414.369 | 296.715 | 224.562 | 187.702 | 181.512 | 150.537 | 131.51 | 100.355 | 74.384 | 42.266 | 31.882 |
Net Income Ratio
| 0.101 | 0.12 | 0.114 | -0.229 | 0.126 | 0.184 | 0.214 | 0.245 | 0.188 | 0.172 | 0.172 | 0.205 | 0.201 | 0.205 | 0.182 | 0.154 | 0.105 | 0.098 |
EPS
| 0.32 | 0.4 | 0.35 | -0.54 | 0.4 | 0.54 | 0.52 | 0.55 | 0.41 | 0.31 | 0.26 | 0.25 | 0.21 | 0.18 | 0.19 | 0.14 | 0.078 | 0.11 |
EPS Diluted
| 0.32 | 0.4 | 0.35 | -0.54 | 0.4 | 0.53 | 0.52 | 0.54 | 0.4 | 0.31 | 0.26 | 0.25 | 0.21 | 0.18 | 0.19 | 0.14 | 0.078 | 0.11 |
EBITDA
| 511.616 | 540.572 | 539.339 | 486.68 | 617.206 | 630.029 | 556.981 | 562.846 | 414.852 | 313.014 | 251.08 | 241.582 | 198.386 | 169.593 | 127.671 | 105.873 | 68.59 | 49.746 |
EBITDA Ratio
| 0.196 | 0.202 | 0.222 | 0.257 | 0.244 | 0.267 | 0.284 | 0.333 | 0.263 | 0.239 | 0.23 | 0.273 | 0.264 | 0.265 | 0.231 | 0.219 | 0.17 | 0.152 |